Health officials made the declaration after the DRC went 42 days with no new cases since the last survivor tested negative and was discharged from an Ebola treatment unit.
As of February 25, Guinea had 9 Ebola cases and deaths; the United States will begin travel restrictions from 2 African nations where the Ebola virus is beginning to circulate.
Regardless of interval or dose level, both heterologous and homologous Ad26, MVA Ebola vaccine regimens were observed to be well tolerated in healthy adults.
Atoltivimab, maftivimab, and odesivimab-ebgn is a combination of Zaire ebolavirusglycoprotein directed recombinant human IgG1 human monoclonal antibodies.
A recent study examining Ebola virus disease survival and intravenous fluid administration brings to light broader knowledge gaps about survival management that should be studied further.
A single monoclonal antibody, mAb114, targeting the receptor-binding domain of Ebola virus glycoprotein showed linear pharmacokinetics and was easily and rapidly infused.